These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18401552)

  • 41. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
    Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y
    Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization.
    Adán A; Mateo C; Navarro R; Bitrian E; Casaroli-Marano RP
    Retina; 2007; 27(9):1180-6. PubMed ID: 18046222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin).
    Nicolò M; Ghiglione D; Calabria G
    Eur J Ophthalmol; 2006; 16(5):770-3. PubMed ID: 17061236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
    Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal injection of bevacizumab for the treatment of choroidal neovascularization in a patient with angioid streaks.
    Liu YC; Yang CS; Shyong MP; Lee FL; Lee SM
    J Chin Med Assoc; 2009 Feb; 72(2):98-102. PubMed ID: 19251540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population.
    Azad RV; Khan MA; Chanana B; Azad S
    Jpn J Ophthalmol; 2008; 52(1):52-6. PubMed ID: 18369701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.
    Yamamoto I; Rogers AH; Reichel E; Yates PA; Duker JS
    Br J Ophthalmol; 2007 Feb; 91(2):157-60. PubMed ID: 16870653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.
    Spaide RF; Laud K; Fine HF; Klancnik JM; Meyerle CB; Yannuzzi LA; Sorenson J; Slakter J; Fisher YL; Cooney MJ
    Retina; 2006 Apr; 26(4):383-90. PubMed ID: 16603955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extrafoveal choroidal neovascularization secondary to wet age-related macular degeneration treated with intravitreal bevacizumab.
    Mones JM; Lopez MA; Prieto JA; Rodriguez JP
    Ophthalmic Surg Lasers Imaging; 2007; 38(3):226-8. PubMed ID: 17552389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G
    Retina; 2006; 26(5):495-511. PubMed ID: 16770255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis.
    Guthoff R; Goebel W
    Acta Ophthalmol; 2009 Sep; 87(6):688-90. PubMed ID: 18631326
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
    Teixeira A; Mattos T; Velletri R; Teixeira R; Freire J; Moares N; Bonomo PP
    Ophthalmic Surg Lasers Imaging; 2010; 41(5):546-9. PubMed ID: 20795575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization.
    Arias L; Caminal JM; Rubio M; Pujol O; Arruga J
    Eur J Ophthalmol; 2007; 17(6):992-5. PubMed ID: 18050131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy.
    Ghajarnia M; Kurup S; Eller A
    Semin Ophthalmol; 2007; 22(2):127-31. PubMed ID: 17564935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antiangiogenic therapy for choroidal neovascularization induced by age-related macular degeneration (preliminary communication)].
    Avetisov SE; Mamikoian VR; Surguch BK; Sdobnikova SV
    Vestn Oftalmol; 2009; 125(6):3-8. PubMed ID: 20143531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome.
    Wu L; Evans T; Saravia M; Schlaen A; Couto C
    Jpn J Ophthalmol; 2009 Jan; 53(1):57-60. PubMed ID: 19184312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta.
    Rishi P; Rishi E; Venkatraman A
    Indian J Ophthalmol; 2012; 60(3):229-31. PubMed ID: 22569391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study.
    Giansanti F; Virgili G; Bini A; Rapizzi E; Giacomelli G; Donati MC; Verdina T; Menchini U
    Eur J Ophthalmol; 2007; 17(2):230-7. PubMed ID: 17415697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravitreal bevacizumab.
    Lucas RS; McKee HD; Lee LR
    Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
    [No Abstract]   [Full Text] [Related]  

  • 60. Necessity of paracentesis before or after intravitreal injection of bevacizumab.
    Huang WC; Lin JM; Chiang CC; Tsai YY
    Arch Ophthalmol; 2008 Sep; 126(9):1314-5; author reply 1315. PubMed ID: 18779502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.